SCHEDULE: Nomura Holdings Discloses 1.6% Stake in Charles River Labs
Beneficial Ownership Disclosure
Nomura Holdings Inc. has reported a 1.6% beneficial ownership stake in Charles River Laboratories International, Inc. as of September 30, 2025.
Summary
- Nomura Holdings Inc. beneficially owns 807,923 shares of Common Stock in Charles River Laboratories International, Inc.
- This ownership represents 1.6% of the class of securities outstanding.
- The percentage is calculated based on 49,215,000 shares of Common Stock outstanding as of September 27, 2025, as reported in the Issuer's quarterly report on Form 10-Q filed on November 5, 2025.
- The shares are held with sole voting power and sole dispositive power by Nomura Holdings Inc. through its wholly-owned subsidiaries: Nomura Global Financial Products, Inc. (806,275 shares), Nomura Securities International, Inc. (468 shares), and Nomura International PLC (1,180 shares).
- Nomura Holdings Inc. certified that the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: This is a routine regulatory disclosure of passive beneficial ownership, providing factual information without expressing positive or negative sentiment regarding the issuer's performance or outlook.
Future Outlook
NA
Management Comments
- Nomura Holdings Inc. certified that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.
Industry Context
Charles River Laboratories International, Inc. operates in the life sciences industry, providing drug discovery, development, and safety assessment services. This filing reflects a passive investment by a major global financial services group, Nomura Holdings Inc., in a company within this sector.
Key Dates
| Date | Description |
|---|---|
| 09/27/2025 | Date as of which 49,215,000 shares of Common Stock were outstanding, used for percentage calculation. |
| 09/30/2025 | Date of event which required the filing of this statement. |
| 11/05/2025 | Date Issuer's quarterly report on Form 10-Q for the fiscal quarter ended September 27, 2025, was filed with the SEC. |
| 11/14/2025 | Date of signing and filing of this Schedule 13G. |
Keywords
Nomura Holdings, Charles River Laboratories, beneficial ownership, Schedule 13G, institutional investment, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.